PolTREG S.A. announced it received a Notice of Allowance from the United States Patent and Trademark Office, covering the manufacturing of T-regulatory cells to treat Type-1 Diabetes, and ways the therapy is administered.
PolTREG S.A. announced it received a Notice of Allowance from the United States Patent and Trademark Office, covering the manufacturing of T-regulatory cells to treat Type-1 Diabetes, and ways the therapy is administered.